Jeffrey H. Murray

Array ( [id] => 10831414 [patent_doc_number] => 08859583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/275786 [patent_app_country] => US [patent_app_date] => 2011-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41094 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13275786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9004452 [patent_doc_number] => 20130225577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'BICYCLIC DIAMINES AS JANUS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/880767 [patent_app_country] => US [patent_app_date] => 2011-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24208 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496588 [patent_doc_number] => 08735403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Inhibitors of Bruton\'s tyrosine kinase' [patent_app_type] => utility [patent_app_number] => 13/249066 [patent_app_country] => US [patent_app_date] => 2011-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 42904 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13249066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286276 [patent_doc_number] => 08642606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'ZAP-70 active compounds' [patent_app_type] => utility [patent_app_number] => 13/244071 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16446 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13244071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720868 [patent_doc_number] => 20120010203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS' [patent_app_type] => utility [patent_app_number] => 13/243118 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61114 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010203.pdf [firstpage_image] =>[orig_patent_app_number] => 13243118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413671 [patent_doc_number] => 08697708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Azabenzothiazole compounds, compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 13/232778 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92494 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 4114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13232778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382267 [patent_doc_number] => 20120225888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Inhibitors of Human Immunodeficiency Virus Replication' [patent_app_type] => utility [patent_app_number] => 13/224802 [patent_app_country] => US [patent_app_date] => 2011-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52810 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13224802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884841 [patent_doc_number] => 20130158025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/819601 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 46707 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670141 [patent_doc_number] => 20110319410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'PYRAZINE DERIVATIVES AND USE AS PI3K INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/222045 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49332 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13222045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663691 [patent_doc_number] => 20110312960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'PYRAZINE DERIVATIVES AND USE AS PI3K INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/222072 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49331 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312960.pdf [firstpage_image] =>[orig_patent_app_number] => 13222072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9995947 [patent_doc_number] => 09040545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'Heterocyclyl pyrazolopyrimidine analogues as selective JAK inhibitors' [patent_app_type] => utility [patent_app_number] => 13/816555 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39828 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898165 [patent_doc_number] => 08921379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Fused ring compound and use thereof' [patent_app_type] => utility [patent_app_number] => 13/205967 [patent_app_country] => US [patent_app_date] => 2011-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 341615 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13205967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808208 [patent_doc_number] => 20120059162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION' [patent_app_type] => utility [patent_app_number] => 13/192369 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83316 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20120059162.pdf [firstpage_image] =>[orig_patent_app_number] => 13192369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160310 [patent_doc_number] => 20120101109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'ETHANOLAMINE SALT OF N- (3-METHOXY-5-METHYLPYRAZIN-2YL) -2- (4-[1, 3, 4-OXADIAZOLE-2-YL] PHENYL) PYRIDINE-3- SULPHONAMIDE' [patent_app_type] => utility [patent_app_number] => 13/189818 [patent_app_country] => US [patent_app_date] => 2011-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10259 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101109.pdf [firstpage_image] =>[orig_patent_app_number] => 13189818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265914 [patent_doc_number] => 20120165348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 13/137125 [patent_app_country] => US [patent_app_date] => 2011-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12690 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13137125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10025068 [patent_doc_number] => 09066948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines' [patent_app_type] => utility [patent_app_number] => 13/810587 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28012 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552296 [patent_doc_number] => 08759344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 13/808503 [patent_app_country] => US [patent_app_date] => 2011-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23355 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10525847 [patent_doc_number] => 09252369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-02 [patent_title] => 'Metal complexes with organic ligands and use thereof in OLEDs' [patent_app_type] => utility [patent_app_number] => 13/809196 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11601 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9183937 [patent_doc_number] => 08623869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Compounds useful as inhibitors of ATR kinase' [patent_app_type] => utility [patent_app_number] => 13/167654 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23921 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13167654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211467 [patent_doc_number] => 20120129876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => '[4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL)-PHENYL]-5-CHLORO-THIOPHEN-2-YL-SULFONYLUREA SALTS, FORMS AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 13/166763 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 84 [patent_figures_cnt] => 84 [patent_no_of_words] => 35665 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129876.pdf [firstpage_image] =>[orig_patent_app_number] => 13166763 [rel_patent_id] =>[rel_patent_doc_number] =>)